Shell Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$57K Sell
5,376
-6,671
-55% -$65.5K 0.01% 821
2025
Q2
$117K Sell
12,047
-2,697
-18% -$27.8K ﹤0.01% 959
2025
Q1
$220K Sell
14,744
-78
-0.5% -$1.2K 0.01% 755
2024
Q4
$221K Hold
14,822
0.01% 798
2024
Q3
$284K Buy
+14,822
New +$307K 0.01% 713
2024
Q1
$324K Buy
15,674
+9,740
+164% +$167K 0.01% 643
2023
Q4
$86K Sell
5,934
-1,790
-23% -$24.4K ﹤0.01% 1096
2023
Q3
$134K Sell
7,724
-122
-2% -$2.54K 0.01% 1017
2023
Q2
$163K Sell
7,846
-45
-0.6% -$978 0.01% 987
2023
Q1
$186K Sell
7,891
-28
-0.4% -$752 0.01% 947
2022
Q4
$221K Sell
7,919
-1,609
-17% -$41.1K 0.01% 919
2022
Q3
$223K Sell
9,528
-2,496
-21% -$75.4K 0.01% 966
2022
Q2
$406K Buy
12,024
+20
+0.2% +$701 0.01% 824
2022
Q1
$419K Sell
12,004
-1,781
-13% -$60.9K 0.01% 895
2021
Q4
$420K Buy
+13,785
New +$449K 0.01% 975
2021
Q3
Sell
-25,254
Closed -$764K 1460
2021
Q2
$764K Buy
+25,254
New +$831K 0.01% 698

Other funds holding OGN

Shell Asset Management's OGN Position: Q3 2025 in Review

Shell Asset Management reduced its Organon & Co (OGN) stake by 55% in Q3 2025, selling an estimated $65.5K and leaving 5,376 shares worth $57K. The position accounts for 0.01% of the portfolio, ranked #821.

Shell Asset Management first reported a position in OGN in Q2 2021 and has held it in 16 quarters since. The position peaked at $764K in Q2 2021. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Shell Asset Management held 5,376 shares of Organon & Co worth $57K as of Q3 2025.
  • Shell Asset Management sold 6,671 Organon & Co shares in Q3 2025, an estimated $65.5K.
  • Organon & Co made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #821 holding.
  • Shell Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 16 quarters since.
  • Shell Asset Management's Organon & Co position peaked at $764K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.